RPGLIFEPharmaceuticals
RPG Life Sciences Ltd — PE Ratio & Valuation Analysis
₹1857.70
-2.96%
Current P/E33.04xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E30.5x8.2% above avg
⚠️
4.0% Premium to Industry
RPGLIFE P/E 33.04x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹110.80 | ₹2322 | 21x |
| 2024 | ₹53.01 | ₹2184 | 41.2x |
| 2023 | ₹40.90 | ₹1336 | 32.7x |
| 2022 | ₹31.13 | ₹847 | 27.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding RPG Life Sciences Ltd Valuation
RPG Life Sciences Ltd (RPGLIFE) currently trades at 33.04x earnings. The Pharmaceuticals sector average PE is 31.77x. RPGLIFE commands a premium, reflecting high growth expectations. Historically, RPGLIFE has traded at an average PE of 30.5x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
25.53%
Dividend Yield
0.90%
More on RPG Life Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.